Mylan set to get go-ahead from Brussels for Meda AB takeover
Mylan was expected to get the 'green light' from European regulators for its takeover bid for Sweden's Meda AB after it agreed to sell some assets, Reuters reported citing two people familiar with the discussions.
Meda
kr0.00
16:46 26/04/24
0.00%
kr0.00
Mylan Inc.
$0.00
19:30 08/12/22
0.00%
$0.00
Nasdaq 100
17,718.30
12:15 26/04/24
1.65%
287.79
The US generic drugs maker offered $7.2bn in shares and cash for Meda in February, its third attempt to take over its Nordic rival.
EU competition authorities were set to issue their own ruling on 20 July.
A successful transaction would allow Mylan to enter several emerging markets it which it did not already operate, including China, Russia and the Middle East.
As of 17:31 BST shares in Mylan were drifting lower by 0.04% to $45.33.